35406-31-6
35406-31-6
Chemical Structure
Tetrahydrohonokiol
- CAS No.: 35406-31-6
- Formula:C18H22O2
- Molecular Weight:270.37
IUPAC Name: 3',5-dipropyl-[1,1'-biphenyl]-2,4'-diol
InChIKey: PJBHWFHBOPMXAM-UHFFFAOYSA-N
SMILES: OC1=CC=C(C=C1C=2C=CC(O)=C(C2)CCC)CCC
Biological Activity: Tetrahydrohonokiol is a hydrogenated biphenyl neolignan derived from Honokiol (HY-N0003) through hydrogenation reduction. Tetrahydrohonokiol possesses potential antitumor activity. Tetrahydrohonokiol can be used for cancer research[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Tetrahydrohonokiol | Tetrahydrohonokiol is a hydrogenated biphenyl neolignan derived from Honokiol (HY-N0003) through hydrogenation reduction. Tetrahydrohonokiol possesses potential antitumor activity. Tetrahydrohonokiol can be used for cancer research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Fujita, et al. Honokiol, a New Phenolic Compound isolated from the Bark of Magnolia obovata THUNB. Chemical & Pharmaceutical Bulletin, vol. 20, no. 1, 1972, pp. 212–213.
- [2]. Bernaskova M, et al. Synthesis of tetrahydrohonokiol derivates and their evaluation for cytotoxic activity against CCRF-CEM leukemia, U251 glioblastoma and HCT-116 colon cancer cells. Molecules (Basel, Switzerland). 2014 Jan 20;19(1):1223-37.
